Press Releases

Results found (114)
May 17, 2012
Yissum Spin Off Avraham Pharmaceuticals Announces Commencement of a Phase 2...

Yaacov Michlin appointed Chairman of the Board and Dr. Yona Geffen appointed Chief Executive Officer

May 15, 2012
Yissum Introduces a Novel Method for Improving Fish Farming

Technology, to be presented at Agritech Israel 2012, enables better control over fish reproduction cycle, increasing spawning and fish size 


March 5, 2012
Yissum Yissum Signs Licensing Agreement with Dow AgroFresh for a Novel...

Yissum, the research and development company of the Hebrew University of Jerusalem, North Carolina State University, Raleigh , N.C., and Dow AgroFresh, a business unit of Rohm and Haas Company, a wholly owned subsidiary of The Dow Chemical...

December 19, 2011
Atox Bio Raises $3.25 million to Advance Development of AB103, a Novel...

Atox Bio will be included as one of the portfolio companies of Integra Holdings, a holding company currently formed by Yissum, the technology transfer company of the Hebrew University of Jerusalem.

December 19, 2011
Yissum Introduces a Novel Technology for Manufacturing an Anti-Malaria Drug...

The work was published in the latest issue of the prestigious Nature Biotechnology journal 

November 16, 2011
Yissum Introduces a Novel, Environmentally-Friendly Biological Solution for...

Technology to be presented at WATEC, the Water Technologies, Renewable Energy and Environmental Control Exhibition and Conference 

November 14, 2011
Yissum, Pontifax, Clal Biotechnology Industries, TRDF and Other Investors...

Yissum will now maintain 30% holding share in Avraham Pharmaceuticals, which will be transferred to its forthcoming biotech holdings company 

November 2, 2011
Yissum Out-licenses a Breakthrough Seed Improvement Technology to Morflora

The novel technology has been proven effective in a number of plant species

October 4, 2011
General Motors and Yissum Sign Research Collaboration Agreement

The first research funded focuses on forecasting of car sales

July 28, 2011
Yissum Introduces Novel Markers for Brain Cancer Survival Prognosis and a...

The biomarkers discovered by Dr. Karni and the post-doctoral researcher Dr. Regina Golan-Gerstel from the Department of Biochemistry and Molecular Biology are more precise than existing markers, and enable accurate survival prognosis of...

June 27, 2011
Biolinerx signs exclusive license agreement with Yissum for oral phase ii...

BL-7040 has dual activity on both the nervous and immune systems, rendering it highly suitable for treating both neurological diseases and immune system related conditions such as inflammatory or autoimmune diseases. It was invented by HUJI...

June 21, 2011

The device was presented for the 1st time at the Israeli Presidential Conference, which is held in collaboration with the Hebrew University of Jerusalem